Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

MRI-directed contrast enhanced mammography could serve as a useful stand-alone or complimentary tool for biopsy planning when suspicious lesions are detected. 

Munir Ghesani, MD, president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and system chief of nuclear medicine at Mount Sinai Health, explains PSMA-PET has seen rapid adoption because it can significantly improve prostate cancer detection and treatment. 
 

A fully automated body composition analysis derived from CT imaging can be a valuable pretreatment tool for patients with colorectal cancer. 

In a close collaboration with radiation oncologists, experts trained their model on the CT lung images of 787 patients and tested it on the scans of more than 1,300 patients from external datasets.

When applied to MRI and clinical features, different machine learning models were recently shown to reliably predict post-treatment recurrences of hepatocellular carcinoma. 

The new findings findings represent “a step toward improved tumor diagnoses," according to authors of a new study published in JAMA.

Implementing an EHR cancer tracking system to review radiology reports for abnormal findings resulted in patients at one Veterans Affairs Hospital receiving their cancer diagnosis and treatment months earlier than those who were imaged before the system was put into place.